Skyepharma Competitors and Similar CompaniesClear all
Avid Bioservices's competitors and similar companies include Amicus Therapeutics and Societal CDMO.
 Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | |
Founding Date | Founding Date 1981 | Founding Date 2002 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tustin, US HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Gainesville, US HQ Gainesville, US San Diego, US |
Employees | Employees 21114% increase | Employees 58415% increase | Employees 21316% decrease |
Valuation ($) | Valuation ($) 672.4 m | Valuation ($) 3.4 b | Valuation ($) 116.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $399.4m (FY, 2023) | Revenue (est.) $94.6m (FY, 2023) |
Cost of goods | Cost of goods $132.6m (FY, 2024) | Cost of goods $37.3m (FY, 2023) | Cost of goods $76.5m (FY, 2023) |
Gross profit | Gross profit $7.3m (FY, 2024) | Gross profit $362m (FY, 2023) | Gross profit N/A |
Net income | Net income ($140.8m) (FY, 2024) | Net income ($151.6m) (FY, 2023) | Net income ($13.3m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companySocietal CDMO
HQ
Gainesville, US
Employees
213↓ 16% decrease
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company